news
Oxford Global’s free webinars: “drug discovery – what will the future hold?” registration open
4 March 2016 | By Oxford Global
This upcoming webinars hosted by Oxford Global will provide an insight on Drug Discovery & Antibody Research...
List view / Grid view
Oxford Global
news
Registration has now opened for Oxford Global’s 17th Annual Drug Discovery Leaders Summit
13 January 2016 | By Oxford Global
Oxford Global Conferences are proud to present the successful 17th Annual Drug Discovery Leaders Summit and co-located 4th Annual Discovery Chemistry & Drug Design Congress taking place on the 13th & 14th June in Berlin...
news
An interview with Bernardo Perez-Ramirez, Sanofi, speaker at the 9th Annual Proteins & Antibodies Congress, 18-19 April 2016, London, UK
13 January 2016 | By Oxford Global
In anticipation of our Proteins and Antibodies Congress, Bernardo Perez-Ramirez spoke to us about his research and his expectations...
news
An interview with Uwe Gudat from Merck Serono, speaker at the 4th Annual Biosimilars & Biobetters Congress, 18-19 April 2016, London
13 January 2016 | By Oxford Global
In anticipation of our 4th Annual Biosimilars & Biobetters Congress, we spoke to one our expert speakers about the some of the key issues in the industry...
news
In conversation – Thoughts on the current status of the sequencing industry. An interview with Jacqueline Boultwood, University of Oxford
4 September 2015 | By Oxford Global
In the run up to our 2015 Next Generation Sequencing Congress, Single Cell Congress & Genome Editing Congress we spoke with Jacqueline Boultwood, University of Oxford, a confirmed speaker at the congress, about her thoughts on the current status of the sequencing industry...
news
Final agenda is now available for our 2nd Annual Drug Discovery USA Congress in Boston
4 September 2015 | By Oxford Global
Production is now complete for the 2nd Annual Drug Discovery USA Congress taking place on the 29th & 30th of October 2015 in Boston, USA...
news
Oxford Global’s Q&A session with Drug Discovery USA speaker Matthew Wagoner, a discovery safety specialist from AstraZeneca
31 July 2015 | By Oxford Global
In the run up to our 2nd Annual Drug Discovery USA Congress 2015, we spoke with Matthew Wagoner a discovery safety specialist from AstraZeneca, a confirmed speaker at the congress where he will talk about Bromodomain And ExtraTerminal (BET) Domain Inhibitors Induce A Loss Of Intestinal Stem Cells And Villous…